Report Code: 10535 | Available Format: PDF
The global animal antimicrobials and antibiotics market is growing significantly due to the increasing companion animal ownership, large scale livestock production, and high incidences of animal diseases outbreaks. The increasing demand for pet animals and massive unexplored market in the emerging economies, such as India and China are creating ample opportunities for the growth of the global animal antimicrobials and antibiotics market, at a considerable rate in the coming years. The advanced research and development facilities, and new drug developments by the key players are propelling the demand for effective treatment of animal diseases.
Antimicrobials refer to all agents or substances that kill or act against micro-organisms; whereas, antibiotics are type of antimicrobials that are mostly effective against bacteria. Animals are at higher risk of developing and spreading microbial diseases. Therefore, antimicrobials and antibiotics are used for effective treatment of animal diseases.
Based on animal type, the global animal antimicrobials and antibiotics market can be categorized as companion animals, food producing animals, and others animals. The food producing animal segment leads the animal the global animal antimicrobials and antibiotics market. The major reason for its largest share is the increasing livestock production.
Based on mode of administration, the animal antimicrobials and antibiotics market can be categorized, as oral powders and solutions, premixes, intramammary preparations, injections, and other mode of administration. The premixes segment leads the global antimicrobials and antibiotics market.
The global animal antimicrobials and antibiotics market can be categorized on the basis of product type as penicillins, tetracyclines, macrolides, cephalosporins, aminoglycosides, sulfonamides, and others. The tetracyclines category holds the largest market among all the products of the global antimicrobials and antibiotics market.
Some of the factors driving the growth of the global animal antimicrobials and antibiotics market are increasing demand for livestock products, growing companion animal ownership, up surging incidences of animal diseases outbreak, and increasing awareness about animal diseases. In addition, several government and non-government organizations have developed early warning systems for most of the animal diseases; fueling the growth of the global animal antimicrobials and antibiotics market. However, stringent regulatory approvals, and increasing usage of antibiotics alternatives such as feed-enzymes and probiotics are some of the factors restraining the growth of the global animal antimicrobials and antibiotics market to some extent.
Geographically, North America leads the global animal antimicrobials and antibiotics market, due to high incidences of animal diseases outbreak, excessive livestock product consumption, high companion animal ownership, and increased awareness for animal diseases outbreaks. In addition, the major players of the animal antimicrobials and antibiotics market in North America are investing huge capital for the development of drugs for animal diseases. Asia-Pacific is the fastest growing region in the global animal antimicrobials and antibiotics market. The fastest growth of the region is attributed to increasing livestock population, growing demand for animal antimicrobials, and high incidences of animal diseases. Moreover, the Asia-Pacific animal antimicrobials and antibiotics market is growing, due to increasing disposable income and companion animal ownership, and increasing government involvement in countering animal diseases outbreaks in the emerging countries, such as India and China.
Some of the major players operating in the global animal antimicrobials and antibiotics market are Bayer AG, Vibrac, Merck & Co. Inc., Vétoquinol, Ceva, Novartis AG, Boehringer Ingelheim GmbH, Eli Lilly and Company, Sanofi, and Zoetis.
Get a bespoke market intelligence solution
Our dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws